Literature DB >> 11334981

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.

L H Carvalho1, J C Hafalla, F Zavala.   

Abstract

The enzyme-linked immunospot technique (ELISPOT) relies on the visualization of cytokine secretion by individual T cells following in vitro stimulation with antigen. This assay has been developed and standardized for the quantitative detection of antigen-specific CD8(+) T cells in mice subjected to different immunization protocols [J. Immunol. Methods 181 (1995) 45]. We have identified important variables that affect the efficacy of the ELISPOT assay and in this protocol we describe this methodology in detail. As a model, we used the production of interferon-gamma by CD8(+) T cells from peripheral blood, spleen and liver of mice immunized with malaria sporozoites expressing the H-2K(d)-restricted SYVPSAEQI. This protocol has also been used successfully to detect Th1 and Th2 epitope specific CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334981     DOI: 10.1016/s0022-1759(01)00331-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  24 in total

1.  IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes.

Authors:  Usriansyah Hadis; Graham R Leggatt; Ranjeny Thomas; Ian H Frazer; Eva M Kovacs
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

2.  Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.

Authors:  Jiaren Sun; Batbayar Tumurbaatar; Junhui Jia; Hong Diao; Francis Bodola; Stanley M Lemon; Wendell Tang; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino; Teh-Sheng Chan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.

Authors:  Gloria González-Aseguinolaza; Yurie Nakaya; Alberto Molano; Edward Dy; Mariano Esteban; Dolores Rodríguez; Juan Ramón Rodríguez; Peter Palese; Adolfo García-Sastre; Ruth S Nussenzweig
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells.

Authors:  Michael G Overstreet; Helen Freyberger; Ian A Cockburn; Yun-Chi Chen; Sze-Wah Tse; Fidel Zavala
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

5.  Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.

Authors:  Lisa A Purcell; Kurt A Wong; Stephanie K Yanow; Moses Lee; Terry W Spithill; Ana Rodriguez
Journal:  Vaccine       Date:  2008-07-29       Impact factor: 3.641

6.  Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A.

Authors:  S A Kaba; A Price; Z Zhou; V Sundaram; P Schnake; I F Goldman; A A Lal; V Udhayakumar; C W Todd
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

7.  Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii.

Authors:  K A Wong; A Zhou; A Rodriguez
Journal:  Parasite Immunol       Date:  2008-09       Impact factor: 2.280

8.  A baculovirus dual expression system-based malaria vaccine induces strong protection against Plasmodium berghei sporozoite challenge in mice.

Authors:  Shigeto Yoshida; Masanori Kawasaki; Norimitsu Hariguchi; Kuniko Hirota; Makoto Matsumoto
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

9.  Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection.

Authors:  Yasushi Miyahira; Masaharu Katae; Seiki Kobayashi; Tsutomu Takeuchi; Yoshinosuke Fukuchi; Ryo Abe; Ko Okumura; Hideo Yagita; Takashi Aoki
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity.

Authors:  Sumana Chakravarty; G Christian Baldeviano; Michael G Overstreet; Fidel Zavala
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.